Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
about
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTESNMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27Peptide and protein-based inhibitors of HIV-1 co-receptorsPhages and HIV-1: from display to interplay.PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.Highly potent chimeric inhibitors targeting two steps of HIV cell entryPotent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.Rational design of novel HIV-1 entry inhibitors by RANTES engineeringHighly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.Molecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform.Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES.Phagekines: Screening Binding Properties and Biological Activity of Functional Cytokines Displayed on Phages.An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.
P2860
Q27657257-CE2675A8-9B0C-4D48-8A76-99AF51A2FF42Q27660108-1A7D967B-1BCD-4E99-B77B-484E359981B7Q30352117-B5810BF8-0513-427C-91B3-89FA0D7D11C0Q34273397-9BE74677-9C2E-4752-A99F-93EBBEEBC8E5Q35122309-124E58C7-0DB6-4CA5-8BEF-D648A583FEF0Q35150195-21F1454F-FD57-4DA2-942B-55617A84B9CBQ35617641-DA8A7008-3D46-4B50-A525-134E793FB171Q35718010-2A5F3289-602C-4453-8809-373288CAD208Q36028163-CC2E9163-99E4-4B70-B226-EC6C75AAC516Q36498554-57D210BB-E8BF-4AAD-A0ED-7AC01BFEE0ACQ36793736-F429795A-9C4D-46AF-BEA9-2F07AC11B7FCQ36976659-63E3C0A5-D78E-4F3D-9302-135984805DA7Q37088591-0B060DB2-2A38-4A93-AFB3-D51A9031BBB6Q37368217-567077DC-1B1D-410F-8F0A-6A71BF258ED0Q37692401-DCE89EDA-F624-4A64-938F-845C6A7B6E0BQ38909407-E5659C24-B216-4A24-913F-A6C21AE52387Q38951248-2ADACB37-7BB3-4D2B-8783-A97EE2DB9D1DQ39864280-2F6C97B9-0803-4FDD-9A41-ECA285DAE620Q40115327-423F3392-4EC9-4463-9594-CF4F5EE8955AQ47425474-9B99FF8D-D434-4395-8A7D-D7B91000FBC9Q51778397-7BE5859F-6A61-480E-BFA1-DDA7E09EA1A7
P2860
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human immunodeficiency virus t ...... a library of phage chemokines.
@ast
Human immunodeficiency virus t ...... a library of phage chemokines.
@en
type
label
Human immunodeficiency virus t ...... a library of phage chemokines.
@ast
Human immunodeficiency virus t ...... a library of phage chemokines.
@en
prefLabel
Human immunodeficiency virus t ...... a library of phage chemokines.
@ast
Human immunodeficiency virus t ...... a library of phage chemokines.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... a library of phage chemokines
@en
P2093
Anouk Heimann
Fabrice Cerini
Gianfranco Pancino
Guy Gorochov
Hubert Gaertner
Oliver Hartley
Patrice Debré
Robin E Offord
P2860
P304
P356
10.1128/JVI.77.12.6637-6644.2003
P577
2003-06-01T00:00:00Z